Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.12 AUD 9.09% Market Closed
Market Cap: 16.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Star Combo Pharma Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Star Combo Pharma Ltd
Long-Term Debt Peer Comparison

Comparables:
BXN
MCP
EXL
B
BIO
H
HPC

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Star Combo Pharma Ltd
ASX:S66
Long-Term Debt
AU$3.9m
CAGR 3-Years
7%
CAGR 5-Years
141%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
McPherson's Ltd
ASX:MCP
Long-Term Debt
AU$5.6m
CAGR 3-Years
-30%
CAGR 5-Years
-19%
CAGR 10-Years
-23%
Elixinol Wellness Ltd
ASX:EXL
Long-Term Debt
AU$178k
CAGR 3-Years
-53%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Long-Term Debt
AU$167.8k
CAGR 3-Years
37%
CAGR 5-Years
32%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Long-Term Debt
$3.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Star Combo Pharma Ltd's Long-Term Debt?
Long-Term Debt
3.9m AUD

Based on the financial report for Jun 30, 2024, Star Combo Pharma Ltd's Long-Term Debt amounts to 3.9m AUD.

What is Star Combo Pharma Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
141%

Over the last year, the Long-Term Debt growth was -4%. The average annual Long-Term Debt growth rates for Star Combo Pharma Ltd have been 7% over the past three years , 141% over the past five years .

Back to Top